AMANDA ALLEN: Open Payments
NPI 1033596218 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,131 in 125 payments from 17 companies in 2025. Trend: 2023 $1,956 · 2024 $2,081 · 2025 $2,131
Food & beverage: $2,131
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 36 | $467 |
| Philips North America LLC | 12 | $289 |
| PFIZER INC. | 13 | $230 |
| Actelion Pharmaceuticals US, Inc. | 10 | $196 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $182 |
| E.R. Squibb & Sons, L.L.C. | 7 | $139 |
| Alnylam Pharmaceuticals Inc. | 5 | $121 |
| Novo Nordisk Inc | 4 | $95 |
| Merck Sharp & Dohme LLC | 5 | $83 |
| Amgen Inc. | 3 | $60 |
Products named: LEQVIO, ELIQUIS, Ambulatory Monitoring & Diagnostics Undivided, JARDIANCE, AMVUTTRA, Wegovy, CAMZYOS, OPSUMIT.
Industry payments across TN — which companies pay providers there.
